Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Madrigal Pharmaceuticals (MDGL) Long-Term Debt Issuances (2022 - 2023)

Madrigal Pharmaceuticals (MDGL) has disclosed Long-Term Debt Issuances for 4 consecutive years, with $15.0 million as the latest value for Q3 2023.

  • Quarterly Long-Term Debt Issuances changed N/A to $15.0 million in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $15.0 million through Jun 2024, down 70.0% year-over-year, with the annual reading at $350.0 million for FY2025, N/A changed from the prior year.
  • Long-Term Debt Issuances for Q3 2023 was $15.0 million at Madrigal Pharmaceuticals, roughly flat from $15.0 million in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $50.0 million in Q2 2022, with the low at $15.0 million in Q2 2023.